We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
Read MoreHide Full Article
Shares of Arcadia Biosciences (RKDA - Free Report) surged 105% since it announced on Thursday that it signed a definitive securities exchange agreement with Roosevelt Resources LP to combine the two companies in an all-stock transaction.
Details of the RKDA-Roosevelt Merger
Under the terms of the agreement, the partners of Roosevelt will receive shares of Arcadia Biosciences common stock in exchange for their equity interests. Upon closing, the current Roosevelt equity owners and Arcadia Biosciences shareholders will own approximately 90% and 10% of Arcadia Biosciences' outstanding shares, respectively.
Following the closing of the deal, the new company will be called Roosevelt Resources Inc. and is expected to trade under a new trading symbol. The new entity will be managed by the current Roosevelt management team with the assistance of one or more members of Arcadia Biosciences management.
The deal is expected to close during the first quarter of 2025, subject to regulatory approvals.
Arcadia Biosciences’ Transformation to an Oil & Gas Company
Arcadia Biosciences has been conducting a thorough strategic assessment since July 2023 to identify opportunities for enhancing shareholder value.
In May 2024, Arcadia Biosciences sold its GoodWheat brand to Above Food Corp. During the month, RKDA also sold its Resistant Starch (”RS”) Durum trait to Corteva Agriscience, a subsidiary of Corteva (CTVA - Free Report) . The company received $4.0 million in cash from Corteva.
Roosevelt is a privately held oil and gas company based in Texas. Its primary asset is a 16,208-acre CCUS project in the Texas Permian Basin, planned for development as an EOR project with anticipated peak production of 55,000 gross barrels of oil equivalent per day by 2051.
Arcadia Biosciences will capitalize on Roosevelt’s vast oil and gas assets, particularly its CCUS project. The new entity marks a significant strategic shift for Arcadia Biosciences, transitioning from an agricultural biotech to an oil and gas company.
The combined businesses will enhance shareholder value and streamline operations.
RKDA Stock’s Price Performance
RKDA’s shares have gained 93.2% over the past year compared with the industry's 4.5% growth.
Image Source: Zacks Investment Research
Arcadia Biosciences’ Zacks Rank & Stocks to Consider
CF Industries has an average trailing four-quarter earnings surprise of 10.3%. The Zacks Consensus Estimate for CF’s 2024 earnings is pegged at $6.32 per share. CF’s shares gained 20.6% in the last year.
Ingevity has an average trailing four-quarter earnings surprise of 95.4%. The Zacks Consensus Estimate for NGVT’s 2024 earnings is pegged at $2.55 per share. Its shares gained 25.7% in the last year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
Shares of Arcadia Biosciences (RKDA - Free Report) surged 105% since it announced on Thursday that it signed a definitive securities exchange agreement with Roosevelt Resources LP to combine the two companies in an all-stock transaction.
Details of the RKDA-Roosevelt Merger
Under the terms of the agreement, the partners of Roosevelt will receive shares of Arcadia Biosciences common stock in exchange for their equity interests. Upon closing, the current Roosevelt equity owners and Arcadia Biosciences shareholders will own approximately 90% and 10% of Arcadia Biosciences' outstanding shares, respectively.
Following the closing of the deal, the new company will be called Roosevelt Resources Inc. and is expected to trade under a new trading symbol. The new entity will be managed by the current Roosevelt management team with the assistance of one or more members of Arcadia Biosciences management.
The deal is expected to close during the first quarter of 2025, subject to regulatory approvals.
Arcadia Biosciences’ Transformation to an Oil & Gas Company
Arcadia Biosciences has been conducting a thorough strategic assessment since July 2023 to identify opportunities for enhancing shareholder value.
In May 2024, Arcadia Biosciences sold its GoodWheat brand to Above Food Corp. During the month, RKDA also sold its Resistant Starch (”RS”) Durum trait to Corteva Agriscience, a subsidiary of Corteva (CTVA - Free Report) . The company received $4.0 million in cash from Corteva.
Roosevelt is a privately held oil and gas company based in Texas. Its primary asset is a 16,208-acre CCUS project in the Texas Permian Basin, planned for development as an EOR project with anticipated peak production of 55,000 gross barrels of oil equivalent per day by 2051.
Arcadia Biosciences will capitalize on Roosevelt’s vast oil and gas assets, particularly its CCUS project. The new entity marks a significant strategic shift for Arcadia Biosciences, transitioning from an agricultural biotech to an oil and gas company.
The combined businesses will enhance shareholder value and streamline operations.
RKDA Stock’s Price Performance
RKDA’s shares have gained 93.2% over the past year compared with the industry's 4.5% growth.
Image Source: Zacks Investment Research
Arcadia Biosciences’ Zacks Rank & Stocks to Consider
RKDA currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the basic materials space are CF Industries Inc. (CF - Free Report) and Ingevity Corporation (NGVT - Free Report) . While CF sports a Zacks Rank #1 (Strong Buy) at present, NGVT carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
CF Industries has an average trailing four-quarter earnings surprise of 10.3%. The Zacks Consensus Estimate for CF’s 2024 earnings is pegged at $6.32 per share. CF’s shares gained 20.6% in the last year.
Ingevity has an average trailing four-quarter earnings surprise of 95.4%. The Zacks Consensus Estimate for NGVT’s 2024 earnings is pegged at $2.55 per share. Its shares gained 25.7% in the last year.